Literature DB >> 20838798

Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment.

Charles H Adler, John N Caviness, Marwan N Sabbagh, Holly A Shill, Donald J Connor, Lucia Sue, Virgilio G H Evidente, Erika Driver-Dunckley, Thomas G Beach.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20838798      PMCID: PMC3100801          DOI: 10.1007/s00401-010-0744-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  11 in total

1.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donors.

Authors:  Charles H Adler; Joseph G Hentz; Jeffrey N Joyce; Thomas Beach; John N Caviness
Journal:  Parkinsonism Relat Disord       Date:  2002-12       Impact factor: 4.891

3.  Neuropathology of dementia in Parkinson's disease: a prospective, community-based study.

Authors:  Dag Aarsland; Robert Perry; Andrew Brown; Jan P Larsen; Clive Ballard
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

4.  Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD.

Authors:  Kurt A Jellinger
Journal:  Parkinsonism Relat Disord       Date:  2005-12-05       Impact factor: 4.891

5.  Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.

Authors:  Carmen Cristea Janvin; Jan Petter Larsen; Dag Aarsland; Kenneth Hugdahl
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

6.  Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.

Authors:  Marwan N Sabbagh; Flora Shah; Richard T Reid; Lucia Sue; Donald J Connor; Lars Kristofer N Peterson; Thomas G Beach
Journal:  Arch Neurol       Date:  2006-12

7.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Authors:  Thomas G Beach; Charles H Adler; LihFen Lue; Lucia I Sue; Jyothi Bachalakuri; Jonette Henry-Watson; Jeanne Sasse; Sarah Boyer; Scophil Shirohi; Reed Brooks; Jennifer Eschbacher; Charles L White; Haru Akiyama; John Caviness; Holly A Shill; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2009-04-28       Impact factor: 17.088

8.  Parkinson disease with dementia: comparing patients with and without Alzheimer pathology.

Authors:  Marwan N Sabbagh; Charles H Adler; Tyson J Lahti; Donald J Connor; Linda Vedders; Lars K Peterson; John N Caviness; Holly A Shill; Lucia I Sue; Iryna Ziabreva; Elaine Perry; Clive G Ballard; Dag Aarsland; Douglas G Walker; Thomas G Beach
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

9.  Defining mild cognitive impairment in Parkinson's disease.

Authors:  John N Caviness; Erika Driver-Dunckley; Donald J Connor; Marwan N Sabbagh; Joseph G Hentz; Brie Noble; Virgilio Gerald H Evidente; Holly A Shill; Charles H Adler
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

10.  The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007.

Authors:  Thomas G Beach; Lucia I Sue; Douglas G Walker; Alex E Roher; LihFen Lue; Linda Vedders; Donald J Connor; Marwan N Sabbagh; Joseph Rogers
Journal:  Cell Tissue Bank       Date:  2008-03-18       Impact factor: 1.522

View more
  34 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

Review 2.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

3.  Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease.

Authors:  Kurt Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2011-09-30       Impact factor: 3.575

4.  Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Jennifer G Goldman; Holly Weis; Glenn Stebbins; Bryan Bernard; Christopher G Goetz
Journal:  Mov Disord       Date:  2012-07-06       Impact factor: 10.338

Review 5.  Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Authors:  Jennifer G Goldman; Neelum T Aggarwal; Cynthia D Schroeder
Journal:  Neurodegener Dis Manag       Date:  2015-10-30

6.  The pattern of cortical atrophy in Parkinson's disease with mild cognitive impairment according to the timing of cognitive dysfunction.

Authors:  Ji E Lee; Kyoo H Cho; Myonghwan Kim; Young H Sohn; Phil Hyu Lee
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

Review 7.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

Review 8.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 9.  Mild cognitive impairment in Parkinson's disease.

Authors:  Dag Aarsland; Kolbjørn Brønnick; Tormod Fladby
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

10.  Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Holly A Shill; Marwan N Sabbagh; Terence Wu; Douglas G Walker; Tyler A Kokjohn; Alex E Roher
Journal:  Neurol Res       Date:  2012-09       Impact factor: 2.448

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.